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Understanding host-microbe interactions has been greatly enhanced by our broadening knowledge of the
regulatory mechanisms at the heart of pathogenesis. The ‘‘transcriptomics’’ approach of measuring global
gene expression has identified genes involved in bacterial pathogenesis. More recently, chromatin immuno-
precipitation (ChIP) and hybridization to microarrays (chIP-on-chip) has emerged as a complementary tool
that permits protein-DNA interactions to be studied in vivo. Thus, chIP-on-chip can be used to map the
binding sites of transcription factors, thereby teasing apart gene regulatory networks. In this Review, we
discuss the ChIP-on-chip technique and focus on its application to the study of host-pathogen interactions.The availability of bacterial genome sequences—including those
of all the major pathogens—ushered in the postgenomic era.
Today, a major goal in bacterial genomics is to understand the
gene regulatory networks of bacterial cells and the response of
these networks to environmental signals. Thus, there has been
an explosion in high-throughput techniques designed to
measure the interplay between transcription factors, DNA- and
RNA-associated proteins and RNA polymerase on a global
scale. Here we discuss recent technical advances in the devel-
opment of chromatin immunoprecipitation (ChIP) as a tool for
unraveling regulatory networks in bacteria and in the host-
pathogen interplay.
The development of the DNA microarray was a significant
breakthrough in the study of microbial gene regulation; for the
first time, researchers were able to quantify each individual tran-
script in a cell’s total pool of RNA. This ‘‘transcriptomics’’
approach has been widely used to identify genes expressed
differentially in response to environmental signals and in mutant
strains. Unsurprisingly, this technique found many applications
in the study of host-pathogen interactions, and there are several
excellent examples from in vitro, ex vivo, and in vivo studies
(Grifantini et al., 2002, 2003; Schnappinger et al., 2003; Talaat
et al., 2004). However, while transcriptome analysis provides
information about the RNA content of the cell, it is unable to
reveal the actual regulatory processes that shape gene expres-
sion: the precise binding targets of transcription factors.
ChIP represents a powerful and complementary tool, since it
identifies protein-DNA interactions in vivo (see Table 1 for global
comparison of RNA profiling and chIP approaches). Briefly, ChIP
involves fixing cells using formaldehyde, thereby crosslinking
DNA-binding proteins to the chromosome, followed by cell lysis
and shearing of DNA by sonication. The protein of interest is then
immunoprecipitated with specific antibodies together with any
crosslinked DNA fragments. After reversal of the crosslinks
and purification, DNA can be analyzed in order to detect enrich-
ment of the sequences bound by the protein of interest. Thus,
using ChIP in conjunction with DNA microarray analysis430 Cell Host & Microbe 5, May 21, 2009 ª2009 Elsevier Inc.(ChIP-on-chip) permits DNA binding to be measured on a chro-
mosome-wide scale (Figure 1). ChIP and chIP-on-chip were first
developed for eukaryotic cells and have since found application
in organisms as diverse as bacteriophages (Gonzalez-Huici
et al., 2004), yeast (Harbison et al., 2004; Lee et al., 2002) and
mammals (Boyer et al., 2005; Bulyk, 2006; Cawley et al., 2004),
where the binding of several transcription factors as well as of
chromatin-associated proteins was investigated. Among
bacteria, ChIP-on-chip has been applied most to Escherichia
coli (Grainger et al., 2004, 2005, 2006, 2007), with a smaller
number of studies focused on other bacteria, such as Bacillus
subtilis (Ben-Yehuda et al., 2005; Eichenberger et al., 2004;
Molle et al., 2003a, 2003b), Helicobacter pylori (Danielli et al.,
2006), Caulobacter crescentus (Laub et al., 2002), Mycobacte-
rium bovis BCG (Rodrigue et al., 2007), and Mycobacterium
tuberculosis (Sala et al., 2009).
Despite already being used widely, the range of ChIP applica-
tions continues to expand (see Table 2 for a list of potential uses).
For example, recent work has shown that ChIP can be used to
study RNA-binding proteins by coupling immunoprecipitation
with reverse-transcription PCR analysis. Using this approach, it
was shown that the Drosophila melanogaster Ash1 transcription
factor binds to three noncoding chromatin-associated regula-
tory RNAs (Sanchez-Elsner et al., 2006).
Advantages of ChIP-on-chip over Traditional
Techniques
ChIP has many advantages over traditional genetic and biochem-
ical approaches for studying interactions made by gene regula-
tory proteins. For example, there is no need to construct mutant
strains, meaning that essential proteins can be studied and that
potential polar effects on gene expression are avoided. Addition-
ally, ChIP experiments are performed under physiological condi-
tions, unlike in vitro biochemical assays of DNA binding. Most
importantly, ChIP can be applied in vivo, on a chromosome-
wide scale. This allows the regulons of transcription factors to
be determined directly, avoiding indirect effects on transcription
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cascades, where one regulator controls the expression of many
others (see Table 1). Moreover, since ChIP-on-chip can be used
to quantify the occupancy of RNA polymerase across the chro-
mosome, the technique represents an alternative to trans-
criptomics that does not require RNA isolation, thus avoiding
potential biases due to differential RNA stability.
Designing a ChIP-on-chip Experiment
Planning a ChIP-on-chip experiment involves collecting informa-
tion, when possible, on the protein of interest with respect to its
expression profile (i.e., exponential or stationary phase), require-
ment of cofactors, and need for specific conditions for activity
(e.g., low oxygen tension). Then, the appropriate reference
sample for normalization should be chosen; this is usually repre-
sented by total genomic DNA. Moreover, a number of technical
and biological replicates should be planned in order to overcome
the background noise that comes within these genome-wide
approaches. Finally, there are some technical issues to be ad-
dressed, starting from the crosslinking protocol to the choice
of the antibody to the appropriate controls to perform in order
to estimate the success of the experiment; most of these points
are discussed in the following sections.
Technical Considerations for ChIP-on-chip
Experiments
Formaldehyde crosslinking is supposed to proceed through
the formation of a Schiff base intermediate between the DNA
backbone and formaldehyde, followed by reaction with lysine
or arginine side chains (Fujita and Wade, 2004). This first step
requires some optimization in terms of time and incubation
temperature. In fact, insufficient fixation results in inability to
identify protein-DNA interaction and extended crosslinking times
may cause overaggregation and unnatural interactions. Some-
times, different crosslinkers have been used: for example,
Table 1. RNA Profiling and ChIP-on-chip: A Comparison
Transcriptomics ChIP-on-chip
In vivo technology In vivo technology
Genome-wide approach Genome-wide approach
Unable to reveal the precise
binding sites for the protein
of interest
Identification of the targets for
the protein under study
Unable to reveal regulatory
cascades
Regulatory cascades can be
defined as well as multiprotein
complexes
mRNA stability problems No stability issues
Mutant strains required as
comparison
No need to make mutants
No antibody requirement Need to make antibodies or to
construct strains expressing
tagged proteins
Various tools available for
analysis
Analysis complicated by the
paucity of bioinformatic devices,
especially for prokaryotes
Set up, well established and
widely used
Complex and long; several steps
involvedbifunctional imidoester reagents were a good choice in mapping
the distribution of chromatin-remodeling complexes (Fujita and
Wade, 2004).
Fortunately, the requirement of antibodies for performing
chIP-on-chip does not necessarily involve expression and purifi-
cation of the protein under study. Tagged proteins can also be
used in ChIP-on-chip assays, thus simplifying the logistics,
provided that the tag does not affect protein folding and function,
and does not alter the cellular phenotype (i.e., growth rate,
colony morphology). Once the protein of interest is tagged and
the expressing strain made, immunoprecipitation can be per-
formed with commercial antibodies. For example, a recent study
in M. bovis BCG exploited the Myc tag: it was fused to the genes
coding for all 13 sigma factors, and ChIP-on-chip was carried out
using an anti-tag antibody (Rodrigue et al., 2007). Mooney and
colleagues reported the use of the hemagglutinin epitope (HA)
as a tag for the NusG regulator in E. coli (Mooney et al., 2009).
HA was also used to tag H-NS in Salmonella (Navarre et al.,
2006), obtaining results similar to those achieved when using
native antibodies (Lucchini et al., 2006). ChIP assays in mamma-
lian and plant cells took advantage of the biotin, FLAG, HA, and
Figure 1. Schematic of the ChIP-on-chip Technology
Cells are crosslinked with formaldehyde in order to introduce reversible cova-
lent bonds between proteins and DNA. After cell lysis and shearing of DNA, the
protein of interest is immunoprecipitated together with bound DNA fragments,
which are then decrosslinked, purified, labeled, and hybridized to microarrays.
Finally, after scanning, ChIP-on-chip signals are plotted against genome coor-
dinates to visualize the protein binding sites.Cell Host & Microbe 5, May 21, 2009 ª2009 Elsevier Inc. 431
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Applications Method Examples
Identification of the DNA-binding sites
for transcription factors
ChIP-on-chip (Shimada et al., 2008; Wade et al., 2007)
Study chromatin-associated proteins ChIP-on-chip (Ben-Yehuda et al., 2005; Breier and Grossman, 2007;
Navarre et al., 2006)
Study RNA-binding proteins ChIP associated with RT-PCR (Sanchez-Elsner et al., 2006)
Define the role of unknown proteins ChIP-on-chip (Sala et al., 2009)
Dissecting dynamics of macromolecular complexes ChIP-on-chip (Mooney et al., 2009)
Study response to environmental signals ChIP-on-chip (Danielli et al., 2006; Grainger et al., 2004, 2007)
Study response to drug treatment ChIP-on-chip (Grainger et al., 2005; Sala et al., 2009)
Analysis of host-pathogen interaction ChIP associated with PCR (Chang et al., 2006; Kay et al., 2007; Venza et al., 2008)V5 (short peptide from simian virus 5) tags (de Folter et al., 2007;
Kolodziej et al., 2009).
However, whatever the method of immunoprecipitation,
complex topologies in protein-DNA or protein-protein interac-
tions may mask the epitope(s), and cross-reactivity with nonspe-
cific targets increases background noise, therefore making the
quality of the antibody one of the primary limitations. Thus,
some ChIP-on-chip experiments are prone to false negative
and false positive measurements (Lee et al., 2006).
Controls can be performed before hybridizing immunoprecip-
itated DNA to microarrays. When possible, quantitative PCR on
known binding sites may help in order to evaluate the success of
the ChIP protocol. Finally, results obtained by chIP-on-chip are
usually supported by traditional techniques. For example, the
binding profiles of E. coli RutR and of M. tuberculosis BlaI were
validated by electrophoretic mobility shift assays (EMSA) and
DNase footprinting, and localization of the operator sequence
was further corroborated by 50-ends mapping (Sala et al.,
2009; Shimada et al., 2008).
Analyzing ChIP-on-chip Results
Analysis of chIP-on-chip data can be challenging, particularly
when global DNA-binding proteins are being studied or multiple
datasets are compared. The problem is compounded for micro-
biologists because few custom-designed software packages
are available. Currently, ChIP-on-chip data are most frequently
visualized by uploading binding profiles into genome browsers,
such as Artemis (Rutherford et al., 2000) or the UCSC Genome
Browser (http://genome.ucsc.edu), where peaks correspond to
binding of the factor under study. However, substantial technical
expertise is required to perform screens of binding data that
automatically extract protein-binding sites and their genomic
context. Statistical analysis may be necessary when large data
sets with technical or biological replicates are being examined.
For instance, the genome-wide distribution of SpoIIID in B. sub-
tilis was analyzed using the Rosetta Resolver statistical package
(Eichenberger et al., 2004).
When performing ChIP associated with high-throughput
sequencing technologies (ChIPSeq), all the sequence reads
have to be mapped to a reference genome. This step can be
carried out using algorithms such as BLAT (Kent, 2002) or
SSAHA (Ning et al., 2001), specifically designed to hold thou-
sands of short tags. Additional software solutions are repre-
sented by MAQ (Li et al., 2008a) and SOAP (Li et al., 2008b),432 Cell Host & Microbe 5, May 21, 2009 ª2009 Elsevier Inc.which can improve accuracy in the alignment process. Finally,
downstream analysis involves mapping reads to genome
browsers and peak identification: FindPeaks (Fejes et al., 2008)
and QuEST (Valouev et al., 2008) may be helpful in this last
step of the process.
Data obtained from either ChIP-on-chip or ChIPSeq experi-
ments may require auxiliary software in order to analyze the
immunoprecipitated DNA sequences. This can reveal simple
trends, like any bias in GC content of the precipitated DNA, as
in the case of H-NS binding to DNA (Grainger et al., 2006;
Navarre et al., 2006), or more complicated patterns (for exam-
ple consensus binding sites for transcription factors can be
determined). At present, some algorithms are available for the
identification of binding motifs: BioProspector, MDscan, and
BioOptimizer (Jensen and Liu, 2004; Liu et al., 2004) have
been successfully exploited in several works (Ben-Yehuda et al.,
2005; Eichenberger et al., 2004; Wade et al., 2006).
ChIP-on-chip in Axenic Cultures
Studies performed in E. coli represent the paradigm for ChIP-on-
chip applications in axenic bacterial cultures (Grainger et al.,
2005). The distribution of several transcription factors (MelR,
CRP, FNR, RutR, LexA) has been determined, as has the chro-
mosome-wide binding profile of RNA polymerase with various
sigma factors (Grainger et al., 2004, 2005, 2007; Shimada
et al., 2008; Wade et al., 2005, 2006). Thus, ChIP-on-chip has re-
vealed that some bacterial transcription factors recognize single
binding sites (as in the case of MelR) while others have more
complex distributions (for example CRP and LexA). These
studies have also provided new and deeper insights into gene
regulation. For instance, most binding sites for transcription
factor RutR were mapped within coding regions, suggesting
that it may have some as yet undiscovered function (Shimada
et al., 2008). Similarly, 25% of the binding sites for the RNA poly-
merase s32 subunit were located in genes (Wade et al., 2006).
Furthermore, extensive overlap between s32 and s70 regulons
was described, accounting for the ability of s32 mutants to tran-
scribe heat-shock genes (Wade et al., 2006).
Mooney and coworkers recently highlighted the use of ChIP-
on-chip to dissect multiprotein transcription complexes in
E. coli (Mooney et al., 2009). The distribution of RNA polymerase,
s70, NusA, NusG and r throughout the genome was analyzed
and revealed close association of the sigma factor with RNA
polymerase at promoter regions, whereas r, NusA, and NusG
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(Mooney et al., 2009). The paper constitutes an example of
how in vivo crosslinking and hybridization to arrays could be
used to explain the intricate dynamics of formation and remodel-
ing of macromolecular complexes.
The availability of high-density DNA microarrays for bacteria
other than E. coli has facilitated the application of ChIP-on-chip
to other bacterial systems, including several pathogens. For
instance, the H. pylori Fur protein has been studied and found
to bind to about 200 genomic loci in an iron-dependent manner,
supporting the idea that this protein acts as a pleiotropic regu-
lator (Danielli et al., 2006). Eichenberger and colleagues provided
an extensive analysis of cell differentiation during the sporulation
process in B. subtilis (Eichenberger et al., 2004). Their work
represents an excellent example of integration of transcriptom-
ics and ChIP-on-chip data as it reports gene expression studies
corroborated by the SpoIIID genome-wide regulatory circuit.
Surprisingly, SpoIIID was found to bind to some targets where
it presumably acts as an architectural protein, in addition to its
role as transcriptional regulator (Eichenberger et al., 2004).
Therefore, chIP-on-chip assays revealed a new unexpected
role for a previously described transcription factor.
Another example of combination of expression profiling with
ChIP-on-chip data resulted in global analysis of the CtrA regulon
in C. crescentus (Laub et al., 2002). This protein is one of the four
master regulators of cell-cycle progression (Shen et al., 2008)
and was found to directly control at least 55 genes, some of
them involved in polar morphogenesis (Laub et al., 2002).
The BlaI regulon from M. tuberculosis was recently analyzed
(Sala et al., 2009). Studies with this protein were of particular
interest because, prior to ChIP-on-chip analysis, the biological
role of this protein was unknown. ChIP-on-chip revealed that
the M. tuberculosis BlaI regulon comprises five DNA loci
including the blaI gene itself and others involved in resistance
to b-lactam antibiotics (Sala et al., 2009). Thus, when applied
to nonmodel organisms, ChIP-on-chip is an extremely powerful
approach to define the role of unknown proteins. Additionally,
ChIP-on-chip can reveal unexpected pathways that might shape
the drug discovery process. For example, BlaI binds upstream of
the operon coding for ATP synthase (Sala et al., 2009), suggest-
ing possible links between cell-wall damage and ATP produc-
tion. Targeting an important function such as the b-lactam-
induced molecular mechanism that controls ATP synthesis
opens a new avenue to rational drug design.
Response to drug treatment represents an important topic
when studying pathogenic bacteria. Different drugs determine
different responses in terms of activation or repression of genes.
This was demonstrated in M. tuberculosis using the transcrip-
tomics approach (Boshoff et al., 2004): each drug generates
a typical transcriptional signature, and related drugs share
most of their expression profile. Consequently, knowledge of
transcriptional signatures can be used to predict the mechanism
of action of new compounds.
Importantly, ChIP-on-chip permits changes in DNA binding by
transcription factors, induced by environmental stimuli, to be
measured. For instance, MelR binding to its target region was
shown to occur both in the presence and in the absence of me-
libiose (Grainger et al., 2004), FNR was found to bind to the oper-
ator sites only upon anaerobic conditions (Grainger et al., 2007),and BlaI was released from its binding sites upon b-lactam treat-
ment (Sala et al., 2009). Furthermore, studies performed using
antibodies against RNA polymerase confirmed that ChIP-on-
chip can be exploited to study the global distribution of the tran-
scriptional machinery in different environmental conditions,
including drug treatment (Grainger et al., 2005). For example,
the response of E. coli to rifampicin was described in terms of re-
localization of RNA polymerase as compared to the mock-
treated sample: consistent with the predicted mechanism of
action of this drug (Campbell et al., 2001), the enzyme was
mainly associated with promoter sequences (Grainger et al.,
2005). Response to salicylic acid was also investigated in
E. coli by means of ChIP-on-chip: genes encoding stable RNAs
and proteins were switched off whereas those required to
survive the stress were transcribed (Grainger et al., 2005). As
a consequence, ChIP-on-chip may become a new useful tool
for predicting the mode of action of new molecules by identifying
the different molecular ‘‘signatures’’ generated in terms of
binding profiles of a given protein or enzyme.
RacA and Spo0J: ChIP-on-chip of Proteins Involved
in Chromosome Segregation
As outlined in the examples described so far, ChIP-on-chip has
been mainly applied to transcription factors and to proteins play-
ing relevant roles in mRNA synthesis. However, the technique
can also be useful to study proteins responsible for chromosome
partitioning, sporulation, and segregation, as in the case of
B. subtilis RacA and Spo0J (Ben-Yehuda et al., 2005; Breier
and Grossman, 2007). In particular, Ben-Yehuda and coworkers
demonstrated that RacA binds to at least 25 regions spread
across the chromosomal origin of replication, thus defining
a centromere-like element (Ben-Yehuda et al., 2005). On the
other hand, Spo0J binds to 10 parS sites throughout the
B. subtilis chromosome and spreads around each one, contrib-
uting to chromosome partitioning (Breier and Grossman, 2007).
Therefore, ChIP-on-chip can be exploited for examining biolog-
ical phenomena other than transcription.
H-NS Binding to DNA: Xenogeneic Silencing
H-NS is a small nucleoid-associated protein that binds DNA with
low-sequence specificity (Fang and Rimsky, 2008). It represents
a functional homolog of eukaryotic histones and modulates
global gene expression (Dorman, 2004; Fang and Rimsky,
2008). Recent work described H-NS distribution over the chro-
mosome of E. coli and Salmonella enterica serovar Typhimurium
by means of ChIP-on-chip (Grainger et al., 2006; Lucchini et al.,
2006; Navarre et al., 2006; Oshima et al., 2006). H-NS was found
to bind to AT-rich regions irrespective of genome location and
to some horizontally transferred sequences, including the
S. enterica pathogenicity islands SPI-1 and SPI-4, suggesting
that H-NS targets foreign DNA (Navarre et al., 2006). The func-
tional significance of the binding profile came from the transcrip-
tomic analysis of the hns mutant: among the H-NS-repressed
genes were those related to the aforementioned SPIs and several
open reading frames exhibiting lower GC content than the rest of
the genome (Navarre et al., 2006). These findings were supported
by comparing H-NS and RNA polymerase-binding profiles: H-NS
was found to hamper RNA polymerase association with DNA,
thus acting as a repressor (Lucchini et al., 2006). In this case,Cell Host & Microbe 5, May 21, 2009 ª2009 Elsevier Inc. 433
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sets explained a previously unrecognized role for H-NS: the
‘‘xenogeneic silencing’’ of foreign genes, for a review see Navarre
et al. (2007). Additional insight into silencing alien DNA came from
Cardinale and colleagues who demonstrated the pivotal role
played by r, NusA, and NusG in repressing prophages and other
foreign DNA sequences in E. coli (Cardinale et al., 2008). In the
framework of host-pathogen interactions, this process provides
a means for protecting the bacterial host from potentially
dangerous and pathogenic DNA elements (prophages, transpo-
sons, and insertion sequences) that are usually horizontally
acquired and characterized by different AT:GC content (Cardi-
nale et al., 2008).
Chromatin Immunoprecipitation and Host-Pathogen
Interaction
Recent work involving bacteria and their phages, microbes,
viruses, and mammalian or plant cells has shown that ChIP
can also be used to analyze host-pathogen dynamics. In these
studies, immunoprecipitation was mainly coupled with PCR in
order to overcome the paucity of recovered DNA.
Interesting examples come from the B. subtilis phages F29
and GA-1 (Alcorlo et al., 2007; Gonzalez-Huici et al., 2004).
F29 is one of the best-described lytic bacteriophages of
Gram-positive bacteria, and GA-1 is closely related (Pecenkova
and Paces, 1999). Their p6 protein, essential for phage develop-
ment, is required for viral DNA compaction and replication, and
was also shown to be involved in transcriptional control (Blanco
et al., 1986; Camacho and Salas, 2001). ChIP after infection of
B. subtilis with either F29 or GA-1 demonstrated p6 binding
throughout the F29 and GA-1 genomes, behavior reminiscent
of a histone-like protein (Alcorlo et al., 2007; Gonzalez-Huici
et al., 2004).
In the context of microbe-Eukarya interaction, interferon-g
(IFN-g) is known to play a role in mediating resistance to intracel-
lular pathogens, such as M. tuberculosis (Cooper et al., 1993;
Flynn et al., 1993). IFN-g production was investigated by ChIP
followed by PCR amplification of target regions in T cells after
stimulation with M. tuberculosis (Samten et al., 2005). CREB
(cyclic AMP response element-binding protein) binding to the
IFN-g promoter was demonstrated, thus providing evidence
that CREB stimulates IFN-g production in response to microbial
antigens (Samten et al., 2005). In another study, infection of
macrophages with the opportunistic protozoan Toxoplasma
gondii was found to block access of RNA polymerase II to the
gene coding for TNF-as thus avoiding overexpression of inflam-
matory cytokines and keeping the host alive, thereby allowing
persistence of the pathogen (Leng et al., 2009).
ChIP in cells stimulated with Pseudomonas aeruginosa, an
opportunistic pathogen that can cause severe infections, re-
vealed that it induces proinflammatory mediators such as IL-8
in the human conjunctiva, through recruitment of RelA and
C/EBPb to IL-8 promoter region (Venza et al., 2008). Additional
examples come from studies of the gastric pathogen H. pylori
(Chang et al., 2006; Kim et al., 2007). Expression of the urokinase
plasminogen activator receptor (uPAR) through NF-kB binding
was demonstrated in human gastric carcinoma cells cocultured
with the pathogen (Kim et al., 2007). An elegant study involving
ChIP assays on human cells infected with H. pylori identified434 Cell Host & Microbe 5, May 21, 2009 ª2009 Elsevier Inc.the CagA-mediated signaling pathway that leads to cyclin D1
expression and enhanced host cell survival (Chang et al., 2006).
With respect to plant-pathogen interactions, ChIP has been
used to show that bacteria belonging to the genus Xanthomonas
can exert control on plant cell size thanks to the AvrBs3 tran-
scription factor. It is injected into plant cells by a type III secretion
system and binds to the promoter controlling the expression of
upa20, a plant transcriptional regulator involved in cell size
control (Kay et al., 2007).
A very recent paper reports the first application of ChIP-on-
chip to studying host-pathogen interaction: the binding sites of
the E2 protein from Papillomavirus were identified in human
cervical carcinoma-derived cells (Jang et al., 2009). The authors
describe E2 binding to all active promoters, in association with
RNA polymerase II, Brd4, and trimethylated histone H3. In spite
of its binding profile, E2 did not affect the transcriptional activity
of target genes and a role in keeping the viral genome in tran-
scriptionally active regions was proposed (Jang et al., 2009).
In summary, these examples are representative of the host
response to a variety of pathogens, be they virus, protist, or
bacterium. Interesting and complementary observations may
come from analysis of the pathogen’s response, thus giving
a global view of the intricate dynamics taking place. This point
has already been approached by means of transcriptomics.
For example, Rohde and colleagues systematically dissected
the M. tuberculosis expression profile after invasion of macro-
phages (Rohde et al., 2007b). They generated comprehensive
data sets indicating that adaptation to the phagosome is a rapid
process and that environmental signals such as pH trigger tran-
scriptional responses (Rohde et al., 2007b). A similar and
complementary analysis could be carried out using either tar-
geted ChIP or genome-wide ChIP-on-chip, perhaps associated
with amplification of the recovered DNA.
Some Examples of Transcription Factors Regulating
Pathogenesis
In the framework of host-pathogen interaction, a major role is
played by those transcription factors that are involved in viru-
lence. For example, M. tuberculosis PhoP is the response regu-
lator of a two-component system essential for pathogenicity
(Frigui et al., 2008; Ryndak et al., 2008), and its mutation contrib-
utes to the attenuation of the M. tuberculosis strain H37Ra (Lee
et al., 2008). The role of PhoP in controlling expression of
a number of genes linked to metabolism, hypoxic response,
respiration, and virulence has been extensively studied by
means of RNA technologies (Gonzalo-Asensio et al., 2008; Lee
et al., 2008; Walters et al., 2006). Similarly, the S. enterica
PhoP ortholog controls expression of several genes, most of
them required for virulence and resistance to host-derived anti-
microbial peptides, as outlined by RNA profiling (Groisman and
Mouslim, 2006; Navarre et al., 2005). Another example is repre-
sented by M. tuberculosis EspR, a key regulator of the ESX-1
secretion system that is required for secretion and virulence in
mice (Guinn et al., 2004; Raghavan et al., 2008). Further under-
standing of the actual role played by those proteins may come
from the application of the ChIP-on-chip approach, either in
axenic cultures or within macrophages.
In addition, intracellular pathogens like M. tuberculosis are
characterized by complex lifestyles and have to cope with
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(Rohde et al., 2007a). Moreover, M. tuberculosis often enters
the nonreplicating latent state (Boshoff and Barry, 2005; Wayne
and Sohaskey, 2001), which has been modeled in several ways
and studied by means of transcriptomics (Betts et al., 2002; Vos-
kuil, 2004; Voskuil et al., 2004). Here we anticipate that ChIP-on-
chip could find application in this field as well by defining the
genomic location of RNA polymerase or of transcription factors
involved in these processes.
Conclusions and Perspectives
As outlined in this review, ChIP-on-chip represents a powerful
technique with many potential applications both in axenic
cultures and in host-pathogen interactions. The use of ChIP is
likely to become more widespread as DNA microarrays are
superseded by next-generation DNA sequencing platforms,
such as Solexa/Illumina and 454 (Morozova and Marra, 2008).
By sequencing immunoprecipitated DNA (ChIPSeq) potential
issues arising from array hybridization chemistry, the base
composition of the organism studied, nonspecific probe-DNA
interactions and secondary structure interference can be
avoided. In addition, high-throughput sequencing generates a
large number of reads that are then mapped to the reference
genome and high tag densities are usually interpreted as binding
sites. This makes the technique statistically valid and accurate.
Furthermore, DNA sequencing will make organisms for which
DNA microarrays are not available amenable to a chromosome-
wide ChIP analysis. Some papers have already been published,
reporting the application and validation of this technique to
eukaryotic genomes with a resolution of 50 bp (Johnson et al.,
2007).
In the context of studying protein-RNA interaction, a recent
technique involving in vivo ultraviolet crosslinking and immuno-
precipitation (CLIP) was developed and used to identify targets
for the Nova protein in mouse brain (Ule et al., 2003).
The vast amount of data generated by these genome-wide
approaches will require new tools for the analysis and compar-
ison of the different data sets. Integration of these results will
provide information about colocalization of proteins and will
generate global regulatory maps of genomes. This approach
has already been successfully used for yeast transcription
factors and the regulatory code of the genome of Saccharo-
myces cerevisiaewas defined (Bar-Joseph et al., 2003; Harbison
et al., 2004; Lee et al., 2002). In addition, ChIP profiles and tran-
scriptomic information may be mutually supportive, contributing
to unraveling the mechanisms behind gene expression, as
exemplified here (Eichenberger et al., 2004; Lucchini et al.,
2006; Navarre et al., 2006).
Integration of data from different bilateral studies will be
productive and informative, shedding light on both the host
and the microbe responses. The findings generated within this
systems biology approach will impact on drug discovery
processes as well as on the development of new vaccines.
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